Antiviral strategy for biosecurity—repurposing, broad spectrum antivirals, and combinations by Dan Elton

Note: this is the 2nd ar­ti­cle in a se­ries of ar­ti­cles dis­cussing rad­vac.org re­lated biose­cu­rity ini­ti­a­tives. In my last ar­ti­cle I dis­cussed us­ing yeast to cre­ate “vac­cine fac­to­ries in a tube”. This post was also cross-posted on my Sub­stack. Speed mat­ters dur­ing a pan­demic. Maxwell Tabar­rok has es­ti­mated that if the FDA’s emer­gency use au­tho­riza­tion of Pfizer’s COVID-19 vac­cine had been done four months ear­lier, then about 240,000 lives would have been saved.[1]A...